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INTRODUCTION
Macroamylasemia, a rare but otherwise benign condi-
tion, is characterized by hyperamylasemia or elevated 
serum amylase levels without elevated urine amylase 
and other signs or symptoms (1-6). In macroamylase-
mia, amylase is bound by immunoglobulin, making it 
larger than usual and unable to be i ltered by the kid-
neys, resulting in high serum amylase levels but nor-
mal urine levels (1-6). Various papers report dif erent 
statistics on the incidence of macroamylasemia, it is 
clear that it is more common among adults, although 
cases in infants and children have been reported. As 
hyperamylasemia is the cornerstone for diagnosing 
pancreatitis, a much more serious condition that re-
quires additional work-up and in most cases hospital-
ization, it is important for physicians at the primary or 
secondary level to be able to recognize and diagnose 
macroamylasemia in order to avoid further diagnostic 
and treatment measures, or to avoid changing current 
treatment when considering comorbidity (1-4,7). Fur-
ther testing puts unnecessary strain on various areas 
of the healthcare system taking time for work with 
other patients, not to mention the stress on patients, 
especially when further investigation or treatment is 
generally not required (1-4,7).
An accepted algorithm for coni rming a diagnosis of 
macroamylasemia, at er i rst i nding elevated serum 
amylase without elevated urine amylase, is to subse-
quently test for serum lipase, which together with high 
amylase levels usually suggests pancreatitis (1-4,6,8). 
If serum lipase is normal, kidney function must be 
tested, as abnormal renal function would also cause 
elevated levels (1-4,6). Once normal kidney function 
is coni rmed, renal amylase clearance relative to cre-
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atinine clearance should be calculated (see Appendix); 
normal ratios are between 3% and 5%, where a result 
of less than 1% suggests macroamylasemia (1-4,6,8). 
h e i nal coni rming test is electrophoresis or poly-
ethylene glycol precipitation test and chromatogra-
phy (1,2,8,10). Unfortunately, these methods are not 
routinely used, at least not in Croatia, and laboratories 
are not of ering or performing such tests, but most 
authors would agree that the ratio calculation can be 
considered diagnostic, although there is disagreement 
about the issue (2,4-9,11).
CASE REPORT
A 27-year-old female patient visited doctor’s oi  ce for 
the i rst time. h e patient had no complaints other 
than known fatigue due to sideropenic anemia from 
menstrual bleeding, which the patient regularly fol-
lowed-up with laboratory tests (blood count, iron, 
UIBC, TIBC and ferritin levels), and was taking iron as 
needed. h e patient described gastroesophageal rel ux 
disease (occasional nausea, heartburn and abdominal 
pain), and was aware of elevated serum amylase with-
out elevated urine amylase at er routine check-up with 
laboratory tests a couple of years before. No further 
investigation was undertaken, but the patient regular-
ly underwent laboratory testing for serum and urine 
amylase, and the results were always the same. Her ap-
petite, urine and stool were normal. Menstrual cycles 
were normal, some cycles were abundant, but her last 
gynecologic examination was normal. h e patient did 
not smoke or drink. Allergies were denied and the pa-
tient did not take any regular medication. h e patient 
denied other serious conditions or diseases except for 
scoliosis that was followed-up, treated with an orthosis 
and physical therapy, and operated due to severity. She 
also denied any other signii cant medical history ex-
cept for multiple hospitalizations (more than i ve) as a 
child due to abdominal pain, nausea and vomiting that 
had led to severe dehydration, but no further explana-
tion or diagnosis had ever been found. Family history 
was unremarkable. 
Examination of her previous medical documentation 
coni rmed the patient’s interview, including multiple 
hospitalizations for vomiting and severe dehydration. 
Several tests were performed during this time (labo-
ratory tests, upper gastrointestinal series, abdominal 
ultrasound) and all proved normal, with the exception 
of hiatal hernia, and metabolic acidosis and aceton-
uria. Test results for serum and urine amylase were 
also found and both were within the reference values: 
serum amylase 90 U/L (ref. <90) and urine amylase 
339 U/L (ref. <390).
Physical examination was unremarkable. Fresh labora-
tory test results, just as the patient described, showed el-
evated serum amylase 143 U/L (ref. 23-91) but normal 
urine amylase 57 U/L (ref. <400). Follow up laboratory 
test for serum lipase was normal, 44 U/L (ref. 13-60). 
Renal function was normal and renal amylase clearance 
relative to creatinine clearance was calculated (see Ap-
pendix) and found to be 0.8% (ref. 3%-5%). Although 
the aforementioned hospitalizations were initially mis-
leading, the interview, physical examination and test 
results suggested the diagnosis of macroamylasemia to 
be very likely; only electrophoresis was lacking.
Laboratory tests for celiac disease were negative: se-
rum IgA 1.3 g/L (ref. 0.7-4.0) and anti-tissue transglu-
taminase-IgA (anti-tTG-IgA) <2 RU/mL (ref. negative 
<20, positive >20).
DISCUSSION
Amylase is an enzyme that is responsible for the break-
down of amylase and other starches during digestion. 
It exists as three subtypes, where α-amylase is found 
in animals, including humans, and it is the only one of 
clinical importance (6). 
Although hyperamylasemia is associated with pan-
creatitis in particular, there are other conditions and 
diseases that may present with hyperamylasemia as 
well, all of which would require further investiga-
tions, unlike macroamylasemia, including sialadeni-
tis, pulmonary disease, ovarian cysts, ruptured ectopic 
pregnancy, abdominal trauma, mesenteric infarction, 
perforated peptic ulcer, appendicitis, pelvic inl am-
matory disease, renal failure, mumps and carcinoma 
(1,2,6,8,12). h ings can get tricky when macroamy-
lasemia is found in cases that would normally pres-
ent with hyperamylasemia, as in a case of appendicitis 
presenting with hyperamylasemia as caused by mac-
roamylasemia (6). Another interesting case found 
macroamylasemia in a patient with elevated serum 
amylase levels, elevated urine levels and a raised clear-
ance ratio, not characteristic of macroamylasemia. Af-
ter various tests, it was concluded that elevated serum 
amylase levels were due to macroamylasemia, while 
urine values were due to salivary amylase being pro-
duced by renal cell carcinoma (12). Naturally, these 
patients exhibited other signs and symptoms which 
suggested comorbidity (6,12). Some studies report an 
increased incidence of macroamylasemia in HIV pos-
itive patients, but at least one study refutes this fact 
(13). Macroamylasemia has been reported in a case of 
splenosis at er post-traumatic splenectomy (14). Mac-
roamylasemia was even found while following a case 
of pancreatitis itself (15).
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Although macroamylasemia is generally asymptomat-
ic, a number of cases were detected due to abdominal 
pain, which led to serum and urine amylase measure-
ment, but this does not coni rm a relationship between 
the two (2,6,10). Some authors suggest it is merely a 
coincidence, since amylase is tested more ot en when 
abdominal pain is present (2,10). According to one 
hypothesis, abdominal pain and macroamylasemia are 
ot en found together due to precipitation of macroamy-
lase molecules within the pancreas, although it has not 
yet been proven (2,6).
Finding hyperamylasemia with other autoimmune con-
ditions or diseases is not uncommon either, and could 
indicate macroamylasemia instead of pancreatitis or hy-
peramylasemia associated conditions; examples are sys-
temic lupus erythematosus, rheumatoid arthritis, and 
ulcerative colitis (2,5,7,16). h ere also is a case reported 
in combination with Crohn’s disease (7). Many cases of 
macroamylasemia have been reported together with ce-
liac disease, and one case has even been reported with 
both celiac disease and myasthenia gravis (5,17-19). A 
gluten free diet, gluten being the trigger causing celiac 
disease, has been shown to treat macroamylasemia in 
these cases (17-19). h ere are cases of macroamylase-
mia reported in selective IgA dei ciency (20).
h ere are theories on how macroamylase is formed; one 
is the antigen driven theory where a self antigen cross 
reacts with an antibody for a foreign antigen, and the 
other theory is dysregulation of immune tolerance that 
occurs in autoimmune diseases (2,5,16,20). In this way, 
antibodies are formed, in most cases immunoglobu-
lin A, rarely immunoglobulin G, which react to either 
salivary or pancreatic amylase, or a combination of the 
two, forming immune complexes, more commonly sal-
ivary amylase (2,4,7,9,15). Cases of macroamylasemia 
and macrolipasemia have also been described, which 
especially create confusion as elevated amylase and li-
pase are found in pancreatitis (15,21). Other molecules 
including α-1 antitrypsin, polysaccharides and glyco-
proteins have been shown to form complexes with am-
ylase causing macroamylasemia as well (2,7,9,22).
It has also been suggested that polyclonal gammopathy 
or polyclonal increase of immunoglobulins, ot en pres-
ent in autoimmune and lymphoproliferative diseases, 
may also increase the likelihood of developing mac-
roamylasemia (2,15). Indeed, the condition has been 
associated with lymphoma, multiple myeloma and 
myeloid leukemia (5,7,14,15). Although most authors 
agree that macroamylasemia is a benign condition, di-
agnosed easily enough, which does not require further 
investigation or treatment, due to the correlation be-
tween polyclonal gammopathy and macroamylasemia 
it has been suggested that macroamylasemia without 
any clear cause deserves investigation to rule out auto-
immune or lymphoproliferative disease (2,15).
Macroamylasemia may also be induced, as shown by 
one study where a group of test subjects were infused 
with a hydroxyethyl starch (HES) solution, which is 
a volemic colloid used in the management of hypo-
volemia. h e test subjects were all healthy individuals 
who developed hyperamylasemia at er infusion with 
a HES solution. Hyperamylasemia was proven to be 
of a macroamylase character. As the HES molecules 
broke down, hyperamylasemia or macroamylasemia 
resolved itself. h is study proved macroamylasemia to 
have a potential to be induced iatrogenically as well, 
apart from disease (2,22).
Some papers report that actually there are three types 
of macroamylasemia, i.e. classic type (type 1), where 
serum amylase is elevated, and urine is normal; type 
2, where both are elevated; and type 3, where both are 
normal, but these types have not been studied addi-
tionally (2,11).
In cases of serum amylase activity over 100 U/L, 
macroamylasemia can be coni rmed by electrophore-
sis (1,3). A negative result shows two clearly dei ned 
bands (S and P type amylase), while the presence of a 
‘smeared’ band, caused by an immunoglobulin-amy-
lase complex, coni rms macroamylasemia (8,10,21,23). 
It should be noted that other cases of asymptomat-
ic hyperamylasemia have been described including 
chronic non-pathological hyperamylasemia of pan-
creatic origin, ethnic hyperamylasemia, and familial 
hyperamylasemia (24). 
Macroamylasemia i tted our case perfectly, as there 
were no other symptoms or signs other than elevat-
ed serum amylase to suggest pancreatitis or one of the 
other aforementioned conditions or diseases. Addi-
tional simple and inexpensive laboratory tests and cal-
culations (lipase, renal function, renal amylase clear-
ance relative to creatinine clearance) coni rmed the 
diagnosis despite the lack of a coni rming test such as 
electrophoresis, as all evidence clearly pointed to mac-
roamylasemia. However, upon seeing elevated serum 
amylase, a physician who does not take macroamy-
lasemia into consideration would be forced to inves-
tigate, ordering unnecessary tests and examinations. 
It is unclear why hyperamylasemia was originally ig-
nored in our case, but dei nitive benign diagnosis was 
certainly welcome. Celiac disease was considered due 
to the connection found in the aforementioned cases 
and studies between macroamylasemia and celiac dis-
ease, and the presentation of atypical features of celi-
ac disease in our patient (nonspecii c gastrointestinal 
complaints, iron dei ciency anemia and short stature), 
but was excluded with additional laboratory tests for 
serum IgA and anti-tTG-IgA.
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APPENDIX
Renal amylase clearance relative to creatinine clearance:
Serum creatinine 60 μmol/L (ref. 49-90)
Urine creatinine 2.9 mmol/L (no reference for random 
sample)
Serum amylase 143 U/L (ref. 23-91)
Urine amylase 57 U/L (fef. <400)
Formula  = urine amylase / serum amylase x serum  
  creatinine / urine creatinine x 100
 = 57 U/L / 143 U/L x 60 μmol/L / 2900 
  μmol/L x 100
 = 0.40 x 0.02 x 100
 = 0.80%
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Makroamilazemija je zanimljivo stanje obilježeno hiperamilazemijom bez ikakvih drugih znakova ili simptoma, najčešće 
uzrokovana kompleksima imunoglobulina i amilaze koji se ne mogu izlučiti putem bubrega. Najčešće ne zahtijeva proširenu 
kliničku obradu, ali se mora uzeti u obzir kako bi se izbjegla nepotrebna dijagnostika i liječenje koji mogu predstavljati 
opterećenje za bolesnika i zdravstveni sustav. Nekoliko studija i prikaza opisuju makroamilazemiju zajedno s drugim 
stanjima ili bolestima, a jedna od značajnijih je celijakija gdje je primjena bezglutenske dijete osnova liječenja. Naš slučaj 
predstavlja mladu bolesnicu bez značajnih znakova ili simptoma osim povišene serumske amilaze otkrivene slučajnim 
probirom. Makroamilazemija je potvrđena bez znakova celijakije, a liječenje nije bilo potrebno.
Ključne riječi: hiperamilazemija, laboratorijska dijagnostika, makroamilazemija
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